Repligen | RGEN - 当期純利益

株価
123.46
毎日の変更
-2.97 -2.35%
毎月
3.07%
毎年
0.18%
Q2 予測
114.76




当期純利益 変化する 日付
Agilent USD 305M 129M 2025-12
Align Technology USD 112.77M 22.99M 2026-03
Bio Techne USD 51.05M 13.04M 2026-03
BioMarin Pharmaceutical USD 105.53M 152.1M 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Bruker USD 3.5M 22.5M 2026-03
Charles River Laboratories USD -14.84M 261.71M 2026-03
Danaher USD 1.03B 168M 2026-03
Dentsply International USD -146M 281M 2025-12
General Electric Aerospace USD 1.9B 637M 2026-03
Henry Schein USD 107M 6M 2026-03
Illumina USD 134M 200M 2026-03
IQVIA Holdings USD 274M 240M 2026-03
Mettler Toledo International USD 169.45M 116.31M 2026-03
Myriad Genetics USD -7.9M 19.5M 2025-12
OraSure Technologies USD -19.29M 5.57M 2025-12
Pacific Biosciences Of California USD -40.37M 2.37M 2025-12
Pfizer USD 2.69B 4.34B 2026-03
Repligen USD 8.33M 4.95M 2026-03
Revvity USD 40.72M 57.65M 2026-03
Standard Biotools USD 19.28M 53.97M 2025-12
Thermo Fisher Scientific USD 1.65B 313M 2026-03
Waters USD -72M 297.21M 2026-03
West Pharmaceutical Services USD 138.8M 6.7M 2026-03